bipolar 1 disorder | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

92,306 results for “bipolar 1 disorder”

Vanda Pharmaceuticals Faces Challenges Despite New Drug Launches and Takeover Bids

FDA Greenlights Alzamend Neuro's Phase IIA Trial of Novel Lithium Therapy AL001 for Bipolar Disorder

Bipolar Disorder Pipeline Shows Promise with 22+ Emerging Therapies

FDA Approves Iloperidone (Fanapt®) for Acute Treatment of Bipolar I Disorder

FDA Accepts Review of UZEDY for Bipolar I Disorder Treatment Extension

Biohaven's BHV-7000 Fails Primary Endpoint in Pivotal Bipolar Disorder Trial

FDA Approves First Lamotrigine Oral Suspension for Epilepsy and Bipolar Disorder Treatment

Comprehensive BMJ review identifies most effective bipolar disorder treatments across age groups and mood phases

FDA Accepts Teva's Applications for UZEDY in Bipolar Disorder and AJOVY for Pediatric Migraines

Alzamend Neuro to Present Non-Clinical Data on AL001 at Society of Toxicology 2025

Page 1 of 1723